Press Release Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call 2 hours ago
Press Release Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer Jul 30